Monday, June 14, 2021
Home News Reports Pfizer Inc withdraws application for emergency use authorisation of its Covid-19 vaccine in India

Pfizer Inc withdraws application for emergency use authorisation of its Covid-19 vaccine in India

Pfizer said that the regulators in India needed more information regarding the vaccine, owing to which it was withdrawing the application for emergency use of the Pfizer vaccine.

Pfizer Inc, which has developed a COVID-19 vaccine in collaboration with Germany’s BioNTech, has reportedly withdrawn the application for emergency use of its vaccine in India. The US company, which was the first company to apply for emergency use authorization of its COVID-19 vaccine in the country, took the decision after it participated in the Subject Expert Committee meeting of the Drug Regulatory Authority of India on February 3.

Following the meeting, the company issued a statement in which it said that the regulators in India needed more information regarding the vaccine, owing to which it was withdrawing the application for emergency use of the Pfizer vaccine in India. “Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time”.

It added that it will in the future look to resubmit its application with the additional information that the regulator requires. “Pfizer will continue to engage with the authority and re-submit its approval request with additional information as it becomes available in the near future.”

The US-based company had sought authorisation for the emergency use of its vaccine in India late last year. However, the Drug Regulatory Authority of India gave its approval to two much economical vaccines- the vaccine developed by Oxford University/AstraZeneca and another made in India vaccine developed by Bharat Biotech together with the Indian Council of Medical Research. 

India’s Central Drugs Standard Control Organisation had declined to accept Pfizer’s request for approval unless it participated in a small local trial to determine the vaccine’s safety and immunogenicity for Indians. Indian health officials opined that since the genetic constitution of an Indian can be different from people in Western nations, this is a pre-requisite. The developer has to agree for the local trial to determine if a vaccine is safe and generates an immune response in its citizens.

Serious allergic reaction like Anaphylaxis reported after administration of Pfizer vaccine

The US-based pharma giant Pfizer and its German partner BioNTech had during initial trials of its vaccine had said that they had not found any serious safety concerns and claimed that the vaccine is more than 90% effective. Britain had become the first Western country to authorise the emergency use of a coronavirus vaccine developed by Pfizer and BioNTech. However, following the implementation of the first dose of the vaccination, reports of serious allergic reaction like Anaphylaxis emerged. Anaphylaxis is a life-threatening allergic reaction that occurs rarely after vaccination.

Logistics is another major concern for the US-based vaccine

Besides this, another major issue pertaining to the Pfizer vaccines is its logistics, since the vaccine requires to be stored in minus 70 degrees (-94 F) or below. Amesh Adalja, the senior scholar at Johns Hopkins Center for Health Security, said, “The cold chain is going to be one of the most challenging aspects of the delivery of this vaccination.” Even in the big cities, the hospitals do not have such storage facilities where storing vaccines at ultra-low temperature is possible.

In general, the refrigeration system at most of the storage facilities across the globe store medicines at 2-5 degrees above the freezing point. In such a situation, the Pfizer vaccine will be viable only for five days after which it will spoil. Owing to this, the distribution of the vaccination in the developing countries and rural areas pose as a major challenge.

As compared to the US based vaccine, vaccine of Moderna Inc which works on similar technology as Pfizer, need not be stored at such low-temperature. Vaccines by Johnson & Johnson and Novavax Inc too can be stored at 2-8 degrees, which is in the normal range of storage facilities’ refrigeration units.

  Support Us  

Whether NDTV or 'The Wire', they never have to worry about funds. In name of saving democracy, they get money from various sources. We need your support to fight them. Please contribute whatever you can afford

OpIndia Staffhttps://www.opindia.com
Staff reporter at OpIndia

Related Articles

Trending now

BBC apologises for its coverage of footballer Eriksen’s collapse, it is time they apologise for their grotesque reportage on India’s Covid outbreak too

The western media outlets, including BBC, ought to apologise India for perpetrating racism with their egregious coverage of country's COVID-19 pandemic and linking it with morbid images of burning funeral pyres.

Rahul Gandhi joins in spreading lies about a ‘scam’ by Ram Mandir trust: Here are the facts in 10 simple points

On the 13th of June 2021, Aam Aadmi Party took to Twitter to level grave allegations against the Ram Janmabhoomi Teerth Kshetra.

Islamic NGO with possible terror links raised almost 150 crores to ‘Help India Breath’ amid pandemic, little of it was actually sent

Dubious NGOs with links to terrorist organizations and Pakistani army collected funds on the name of relief to India amid Covid pandemic

Here is the truth about the land deal by Ram Janmabhoomi Teerth Kshetra and how the allegations by likes of AAP are baseless

Shri Ram Janmabhoomi Teerth Kshetra and its head Champat Rai bought an additional piece of land for the purposes of additional construction to facilitate pilgrims who would be travelling to Ayodhya

Adani Group issues clarification over frozen accounts, says media report ‘blatantly erroneous’

Economic Times report had suggested that the National Securities Depository Limited (NSDL) has frozen accounts of three foreign portfolio investors (FPIs) holding shares in the group companies.

Recently Popular

Kamal R Khan calls Mika Singh ‘anpadh gawar sooar’ after the singer released a diss track titled ‘KRK Kutta’: Here is how the feud...

The feud between KRK and Mika Singh descends to calling each other ‘dogs’ and ‘pigs’, here how it unfolded

Here is the truth about the land deal by Ram Janmabhoomi Teerth Kshetra and how the allegations by likes of AAP are baseless

Shri Ram Janmabhoomi Teerth Kshetra and its head Champat Rai bought an additional piece of land for the purposes of additional construction to facilitate pilgrims who would be travelling to Ayodhya

Young billionaire Nikhil Kamath’s account closed by Chess.com as he admits cheating in charity game to defeat Vishwanathan Anand

Nikhil Kamath created quite the flutter recently after he apparently defeated Vishwanathan Anand in a game of chess.

PM Modi kills the manufactured stories about his rift with Yogi Adityanath with just three words

In a rare gesture, PM Modi publicly praised Yogi Adityanath for a scheme amid the manufactured reports about rift between the two

How a ‘liberal’ filmmaker went from criticising Rahul Gandhi to saying ‘I am on your side’ and what it shows

Congress and their loyalists are still not able to get over the shock of not only losing 2019 elections, but BJP outperforming them and itself from the previous term.

Rohingyas settled all over UP with forged Aadhaar, voter IDs, fresh arrests reveal they are getting financial aid too: Report

ADG informed that the Rohingyas have settled in every assembly constituency with forged voter ID cards.
- Advertisement -

 

Connect with us

255,564FansLike
553,042FollowersFollow
24,300SubscribersSubscribe